Coronary Artery Disease Clinical Trials in Atlanta, Georgia

14 studies are recruiting for coronary artery disease in Atlanta, Georgia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

    The objective of this study is to assess the safety and efficacy of the Supira System in providing temporary cardiovascular hemodynamic support in patients undergoing HRPCI. Eligible patients will be randomized to undergo HRPCI with either the Supira System (investigational device) or the commercia…

    Stage
    Not phased
    Ages
    18 to 90
    Site
    Piedmont Heart Institute, Atlanta, Georgia
    Locations
    26 in total
    Run by
    Supira Medical

    See if you can join NCT07296744 on ClinicalTrials.gov

  2. A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

    This study is designed to evaluate the efficacy and safety of intravenously administered YN001 in patients diagnosed with coronary atherosclerosis, who are receiving background therapy for cardiovascular (CV) risk factors management.

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    Emory Healthcare-Emory Heart & Vascular Center - Executive Park, Atlanta, Georgia
    Locations
    56 in total
    Run by
    Beijing Inno Medicine Co., Ltd.

    See if you can join NCT07521007 on ClinicalTrials.gov

  3. Virtue® SAB in the Treatment of Coronary ISR Trial

    A prospective, multi-center, single-blind, randomized (1:1), non-inferiority study comparing clinical outcomes of the Virtue® Sirolimus AngioInfusion™ Balloon (SAB) to the AGENT™ Paclitaxel Drug-Coated Balloon (DCB) in the treatment of coronary artery in-stent restenosis (ISR).

    Stage
    Not phased
    Ages
    18 and older
    Site
    Emory University Hospital, Atlanta, Georgia
    Locations
    22 in total
    Run by
    Orchestra BioMed, Inc

    See if you can join NCT07045194 on ClinicalTrials.gov

  4. Prevail Global Study

    The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Emory University Hospital Midtown, Atlanta, Georgia
    Locations
    79 in total
    Run by
    Medtronic Vascular

    See if you can join NCT06535854 on ClinicalTrials.gov

  5. ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)

    The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Emory University Hospital Midtown, Atlanta, Georgia
    Locations
    19 in total
    Run by
    Emory University

    See if you can join NCT07559903 on ClinicalTrials.gov

  6. IVUS CHIP UPP Registry

    The IVUS CHIP UPP Registry is a prospective, observational, multicenter, single-arm registry. A total of 1010 patients with complex coronary lesions will be enrolled in up to 2 years, with at least 500 men and women. All patients will be treated with IVUS-guided PCI.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Emory University Hospital Midtown, Atlanta, Georgia
    Locations
    18 in total
    Run by
    ECRI bv

    See if you can join NCT06625801 on ClinicalTrials.gov

  7. Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.

    This is a two-part study, comprised of an initial open-label run-in phase (Part 1) in a subset of 3 subjects to provide first data regarding safety, and feasibility of the percutaneous endovascular catheter-facilitated intramyocardial delivery of XC001 in patients with RA due to obstructive CAD. Pa…

    Stage
    Phase 2
    Ages
    18 to 85
    Site
    Emory University, Atlanta, Georgia
    Locations
    14 in total
    Run by
    XyloCor Therapeutics, Inc.

    See if you can join NCT07048808 on ClinicalTrials.gov

  8. REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women

    This is a research study in women to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The other procedure is an o…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Emory University, Atlanta, Georgia
    Locations
    18 in total
    Run by
    Weill Medical College of Cornell University

    See if you can join NCT06399692 on ClinicalTrials.gov

  9. REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities

    This is a research study in minorities to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The other procedure is…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Emory University, Atlanta, Georgia
    Locations
    18 in total
    Run by
    Weill Medical College of Cornell University

    See if you can join NCT06399705 on ClinicalTrials.gov

  10. Prospective Global Registry for the Study of Chronic Total Occlusion Intervention

    Percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is increasingly being performed in patients with advanced coronary artery disease, but there is limited information on the techniques utilized and the procedural outcomes. The goal of this multicenter, investigator initiate…

    Stage
    Not phased
    Ages
    Any age
    Site
    Emory University Hospital- Emory Heart and Vascular Center, Atlanta, Georgia
    Locations
    48 in total
    Run by
    Minneapolis Heart Institute Foundation

    See if you can join NCT02061436 on ClinicalTrials.gov

  11. Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

    The central hypothesis of ROMA:Women is that the use of multiple arterial grafting (MAG) will improve clinical outcomes and quality of life (QOL) compared to single arterial grafting (SAG). The specific aims of ROMA:Women are: Aim 1: Determine the impact of MAG vs SAG on major adverse cardiac and c…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Emory University, Atlanta, Georgia
    Locations
    146 in total
    Run by
    Weill Medical College of Cornell University

    See if you can join NCT04124120 on ClinicalTrials.gov

  12. MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

    This is a multicenter, randomized, single-blind pivotal study to evaluate the safety and efficacy of the MagicTouchTM Drug coated balloon in treatment of small vessels in patients with coronary artery disease. The objective is to establish the safety and efficacy of the Magic TouchTM Drug coated ba…

    Stage
    Not phased
    Ages
    18 to 80
    Site
    Emory University Hospital /Emory School of Medice, Atlanta, Georgia
    Locations
    24 in total
    Run by
    Concept Medical Inc.

    See if you can join NCT06271590 on ClinicalTrials.gov

  13. Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

    Patients undergoing transcatheter aortic valve replacement (TAVR) often have concomitant coronary artery disease (CAD) which may adversely affect prognosis. There is uncertainty about the benefits and the optimal timing of revascularization for such patients. There is currently clinical equipoise r…

    Stage
    Not phased
    Ages
    Any age
    Site
    Piedmont, Atlanta, Georgia
    Locations
    72 in total
    Run by
    University of British Columbia

    See if you can join NCT04634240 on ClinicalTrials.gov

  14. PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm

    This purpose of this trial is to demonstrate 30 day safety and effectiveness outcomes of the KARDION CORY P4 System in subjects who require hemodynamic support during a high-risk PCI procedure.

    Stage
    Not phased
    Ages
    18 to 90
    Site
    Emory University, Atlanta, Georgia
    Locations
    18 in total
    Run by
    Kardion Inc

    See if you can join NCT06445608 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.